Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publikationen/3314-gemcitabine-and-docetaxel-versus-doxorubicin-as-first-line-treatment-in-previously-untreated-advanced-unresectable-or-metastatic-soft-tissue-sarcomas-geddis-a-randomised-controlled-phase-3-trial/autoren